PortfoliosLab logoPortfoliosLab logo
SABS vs. IVVD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SABS vs. IVVD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SAB Biotherapeutics, Inc. (SABS) and Invivyd Inc. (IVVD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SABS achieves a -10.16% return, which is significantly higher than IVVD's -55.47% return.


SABS

1D
-3.45%
1M
-8.94%
YTD
-10.16%
6M
-9.19%
1Y
80.65%
3Y*
-28.43%
5Y*
-49.13%
10Y*

IVVD

1D
-3.51%
1M
-25.17%
YTD
-55.47%
6M
-50.67%
1Y
13.84%
3Y*
-9.52%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SABS vs. IVVD - Yearly Performance Comparison


2026 (YTD)20252024202320222021
SABS
SAB Biotherapeutics, Inc.
-10.16%-1.43%-44.81%16.55%-92.45%-21.19%
IVVD
Invivyd Inc.
-55.47%457.44%-88.75%162.67%-79.34%-65.23%

Correlation

The correlation between SABS and IVVD is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Aug 9, 2021

0.13

Fundamentals

Market Cap

SABS:

$179.96M

IVVD:

$340.64M

EPS

SABS:

-$0.01

IVVD:

-$0.40

PB Ratio

SABS:

0.79

IVVD:

1.68

Total Revenue (TTM)

SABS:

$0.00

IVVD:

$55.87M

Gross Profit (TTM)

SABS:

-$2.35M

IVVD:

$51.92M

EBITDA (TTM)

SABS:

$994.59K

IVVD:

-$79.85M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


SAB Biotherapeutics, Inc.

Invivyd Inc.

Return for Risk

SABS vs. IVVD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SABS
SABS Risk / Return Rank: 7474
Overall Rank
SABS Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
SABS Sortino Ratio Rank: 7373
Sortino Ratio Rank
SABS Omega Ratio Rank: 7272
Omega Ratio Rank
SABS Calmar Ratio Rank: 7878
Calmar Ratio Rank
SABS Martin Ratio Rank: 7777
Martin Ratio Rank

IVVD
IVVD Risk / Return Rank: 5151
Overall Rank
IVVD Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
IVVD Sortino Ratio Rank: 6363
Sortino Ratio Rank
IVVD Omega Ratio Rank: 5858
Omega Ratio Rank
IVVD Calmar Ratio Rank: 4545
Calmar Ratio Rank
IVVD Martin Ratio Rank: 4545
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SABS vs. IVVD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SAB Biotherapeutics, Inc. (SABS) and Invivyd Inc. (IVVD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SABSIVVDDifference
Sharpe ratioReturn per unit of total volatility

+0.87

Sortino ratioReturn per unit of downside risk

+0.51

Omega ratioGain probability vs. loss probability

1.24

1.15

+0.08

Calmar ratioReturn relative to maximum drawdown

2.40

0.22

+2.18

Martin ratioReturn relative to average drawdown

5.41

0.42

+4.98

SABS vs. IVVD - Sharpe Ratio Comparison

The current SABS Sharpe Ratio is 0.97, which is higher than the IVVD Sharpe Ratio of 0.10. The chart below compares the historical Sharpe Ratios of SABS and IVVD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SABSIVVDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.97

0.10

+0.87

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.44

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.44

-0.26

-0.18

Drawdowns

SABS vs. IVVD - Drawdown Comparison

The maximum SABS drawdown since its inception was -99.01%, roughly equal to the maximum IVVD drawdown of -99.36%. Use the drawdown chart below to compare losses from any high point for SABS and IVVD.


Loading charts...

Drawdown Indicators


SABSIVVDDifference

Max Drawdown

Largest peak-to-trough decline

-99.01%

-99.36%

+0.35%

Max Drawdown (1Y)

Largest decline over 1 year

-33.80%

-63.89%

+30.09%

Max Drawdown (3Y)

Largest decline over 3 years

-88.96%

-92.90%

+3.94%

Max Drawdown (5Y)

Largest decline over 5 years

-99.01%

Current Drawdown

Current decline from peak

-97.01%

-98.04%

+1.03%

Average Drawdown

Average peak-to-trough decline

-78.03%

-91.13%

+13.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.97%

32.71%

-17.74%

Volatility

SABS vs. IVVD - Volatility Comparison

The current volatility for SAB Biotherapeutics, Inc. (SABS) is 20.36%, while Invivyd Inc. (IVVD) has a volatility of 30.40%. This indicates that SABS experiences smaller price fluctuations and is considered to be less risky than IVVD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SABSIVVDDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.36%

30.40%

-10.04%

Volatility (6M)

Calculated over the trailing 6-month period

44.46%

68.69%

-24.23%

Volatility (1Y)

Calculated over the trailing 1-year period

83.77%

140.21%

-56.44%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

111.97%

179.10%

-67.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

108.63%

179.10%

-70.47%

Dividends

SABS vs. IVVD - Dividend Comparison

Neither SABS nor IVVD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SABS vs. IVVD - Financials Comparison

This section allows you to compare key financial metrics between SAB Biotherapeutics, Inc. and Invivyd Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M202220232024202520260
13.74M
(SABS) Total Revenue
(IVVD) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SABS and IVVD have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IVVD has higher volatility (30.40%) compared to SABS (20.36%). In terms of maximum drawdown, SABS dropped -99.01% vs IVVD's -99.36%.

SABS currently has the higher Sharpe Ratio (0.97 vs 0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SABS and IVVD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer